Lethal pneumonitis after docetaxel chemotherapy: Case report and review of the literature

Acta Oncologica

Volumn 52, Issue 5, 2013, Pages 1034-1038

  Storaas, Eivind ^a   Holmaas, Gunhild ^a   Gravdal, Karsten ^a   Borretzen, Astrid ^a   Eikesdal, Hans Petter ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE; DEXAMETHASONE; DOCETAXEL; EPIRUBICIN; FLUCONAZOLE; MEROPENEM; PREDNISONE; C REACTIVE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; NITRIC OXIDE; PEGFILGRASTIM; PENICILLIN V; PREDNISOLONE; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; BREAST CARCINOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG TOLERABILITY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LETTER; MEDICAL HISTORY; PRIORITY JOURNAL; THORAX RADIOGRAPHY; BRONCHOSCOPY; CANCER CHEMOTHERAPY; LUNG LAVAGE; LYMPH NODE METASTASIS; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; PNEUMONIA; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE;

EID: 84877345533     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.750734     Document Type: Letter

References (20)

1. Trotti A , Colevas AD , Setser A , Rusch V , Jaques D , Budach V , et al . Ctcae v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment . Semin Radiat Oncol 2003; 13: 176-81 .
2. Min BD , K ang HW, K im WT , K im YJ , Y un SJ , L ee SC , et al . Docetaxel-induced fatal interstitial pneumonitis in a patient with castration-resistant prostate cancer . Korean J Urol 2012; 53: 371-4 .
3. Nagata S , U eda N , Y oshida Y, M atsuda H, M aehara Y . S evere interstitial pneumonitis associated with the administration of taxanes . J Infect Chemother 2010; 16: 340-4 .
4. Read W L, M ortimer J E, P icus J . S evere interstitial pneumonitis associated with docetaxel administration . Cancer 2002; 94: 847-53 .
5. Merad M , Le Cesne A , Baldeyrou P , Mesurolle B , Le Chevalier T . Docetaxel and interstitial pulmonary injury . Ann Oncol 1997; 8: 191-4 .
6. Muller N L , W hite D A , J iang H , G emma A . D iagnosis and management of drug-associated interstitial lung disease . Br J Cancer 2004; 91(Suppl 2): S24-30 .
7. Rossi S E, Erasmus J J, McAdams H P , Sporn TA , Goodman PC . Pulmonary drug toxicity: Radiologic and pathologic manifestations . Radiographics 2000; 20: 1245-59 .
8. Dang C, D 'Andrea G , L ake D , S ugarman S , F ornier M , Moynahan ME , et al . Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible . Clin Breast Cancer 2008; 8: 418-24 .
9. Dang C , F ornier M , S ugarman S , T roso-Sandoval T , Lake D , D'Andrea G , et al . The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in her-2/neu overexpressed/amplifi ed breast cancer . J Clin Oncol 2008; 26: 1216-22 .
10. Citron ML , B erry DA , C irrincione C, H udis C, W iner EP , Gradishar WJ , et al . Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial c9741/cancer and leukemia group b trial 9741 . J Clin Oncol 2003; 21: 1431-9 .
11. Dale D C . C olony-stimulating factors for the management of neutropenia in cancer patients . Drugs 2002; 62(Suppl 1): 1-15 .
12. Mey UJ , M aier A , S chmidt-Wolf IG , Z iske C, F orstbauer H, Banat GA , et al . Pegfi lgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as fi rst-line therapy in elderly patients with diffuse large B cell lymphoma . Support Care Cancer 2007; 15: 877-84 .
13. Brusamolino E , R usconi C , M ontalbetti L , G argantini L , Uziel L , Pinotti G , et al . Dose-dense R-CHOP-14 supported by pegfi lgrastim in patients with diffuse large B-cell lymphoma: A phase II study of feasibility and toxicity . Haematologica 2006; 91: 496-502 .
14. Tolaney SM , P artridge AH , S heib RG , B urstein HJ, Winer EP . Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer . J Clin Oncol 2006; 24: 5330-1 .
15. Semb K A , A amdal S , O ian P . C apillary protein leak syndrome appears to explain fl uid retention in cancer patients who receive docetaxel treatment . J Clin Oncol 1998; 16: 3426-32 .
16. Piccart M J , K lijn J , P aridaens R , N ooij M , M auriac L , Coleman R , et al . Corticosteroids signifi cantly delay the onset of docetaxel-induced fl uid retention: Final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer . J Clin Oncol 1997; 15: 3149-55 .
17. Khan A , M cNally D , T utschka P J , B ilgrami S . P aclitaxelinduced acute bilateral pneumonitis . Ann Pharmacother 1997; 31: 1471-4 .
18. Ramanathan RK , R eddy VV , H olbert JM , B elani CP . Pulmonary infi ltrates following administration of paclitaxel . Chest 1996; 110: 289-92 .
19. Fujimori K , Yokoyama A , Kurita Y , U no K , Saijo N . Paclitaxel-induced cell-mediated hypersensitivity pneumonitis. Diagnosis using leukocyte migration test, bronchoalveolar lavage and transbronchial lung biopsy . Oncology 1998; 55: 340-4 .
20. Goldberg HL, V annice SB . P neumonitis related to treatment with paclitaxel . J Clin Oncol 1995; 13: 534-5 .